Novel Interventions in Heart Failure with Preserved Ejection Fraction -a single centre, randomised double blinded placebo cross-over pilot study using IVABRADINE, to assess the effect on 6 minute walk test, peak oxygen consumption and New York heart association Class of symptoms, from the Flinders Clinical Research group, Flinders University.

Trial Profile

Novel Interventions in Heart Failure with Preserved Ejection Fraction -a single centre, randomised double blinded placebo cross-over pilot study using IVABRADINE, to assess the effect on 6 minute walk test, peak oxygen consumption and New York heart association Class of symptoms, from the Flinders Clinical Research group, Flinders University.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Acronyms NIHEF-2012i
  • Most Recent Events

    • 17 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top